BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17666964)

  • 1. Evaluation of a workplace HIV treatment programme in South Africa.
    Charalambous S; Innes C; Muirhead D; Kumaranayake L; Fielding K; Pemba L; Hamilton R; Grant A; Churchyard GJ
    AIDS; 2007 Jul; 21 Suppl 3():S73-8. PubMed ID: 17666964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a workplace antiretroviral therapy programme in South Africa.
    Charalambous S; Grant AD; Day JH; Pemba L; Chaisson RE; Kruger P; Martin D; Wood R; Brink B; Churchyard GJ
    AIDS Care; 2007 Jan; 19(1):34-41. PubMed ID: 17129856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of HIV/AIDS workplace policies and programmes in southern Africa.
    Mahajan AP; Colvin M; Rudatsikira JB; Ettl D
    AIDS; 2007 Jul; 21 Suppl 3():S31-9. PubMed ID: 17666960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antiretroviral therapy (ART)-related counselling in a workplace-based ART implementation programme, South Africa.
    Stenson AL; Charalambous S; Dwadwa T; Pemba L; Du Toit JD; Baggaley R; Grant AD; Churchyard GJ
    AIDS Care; 2005 Nov; 17(8):949-57. PubMed ID: 16176891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.
    Rosen S; Long L; Sanne I
    Trop Med Int Health; 2008 Aug; 13(8):1005-15. PubMed ID: 18631314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.
    Bekker LG; Myer L; Orrell C; Lawn S; Wood R
    S Afr Med J; 2006 Apr; 96(4):315-20. PubMed ID: 16670804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
    Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
    Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Business and HIV/AIDS: the case of Anglo American.
    Brink B; Pienaar J
    AIDS; 2007 Jul; 21 Suppl 3():S79-84. PubMed ID: 17666965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research.
    Rosen S; Feeley F; Connelly P; Simon J
    AIDS; 2007 Jul; 21 Suppl 3():S41-51. PubMed ID: 17666961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.
    Vo TT; Ledergerber B; Keiser O; Hirschel B; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Weber R;
    J Infect Dis; 2008 Jun; 197(12):1685-94. PubMed ID: 18513155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa.
    Igumbor JO; Scheepers E; Ebrahim R; Jason A; Grimwood A
    AIDS Care; 2011 Feb; 23(2):231-6. PubMed ID: 21259136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa.
    Wouters E; Van Loon F; Van Rensburg D; Meulemans H
    AIDS Care; 2009 Nov; 21(11):1401-11. PubMed ID: 20024717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I; van der Horst C
    J HIV Ther; 2004 Sep; 9(3):65-8. PubMed ID: 15534564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa.
    Page-Shipp LS; Charalambous S; Roux S; Dias B; Sefuti C; Churchyard GJ; Grant AD
    Sex Transm Infect; 2007 Aug; 83(5):383-6. PubMed ID: 17567686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
    Wouters E; Van Damme W; van Rensburg D; Meulemans H
    AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.